𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vitro characterization of the cysteine-rich capping domains in a plant leucine rich repeat protein

✍ Scribed by Olatomirin O. Kolade; Vicki A. Bamford; Gema Ancillo Anton; Jonathan D.G. Jones; Pablo Vera; Andrew M. Hemmings

Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
777 KB
Volume
1764
Category
Article
ISSN
1570-9639

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of the leucine-rich repeat domain o
Role of the leucine-rich repeat domain of cryopyrin/NALP3 in monosodium urate crystal–induced inflammation in mice
✍ Hal M. Hoffman; Peter Scott; James L. Mueller; Amir Misaghi; Sean Stevens; Georg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 386 KB

## Abstract ## Objective The mechanism by which monosodium urate monohydrate (MSU) crystals intracellularly activate the cryopyrin inflammasome is unknown. The aim of this study was to use a mouse molecular genetics–based approach to test whether the leucine‐rich repeat (LRR) domain of cryopyrin i

Functional consequences of a germline mu
Functional consequences of a germline mutation in the leucine-rich repeat domain of NLRP3 identified in an atypical autoinflammatory disorder
✍ Isabelle Jéru; Sandrine Marlin; Gaëlle Le Borgne; Emmanuelle Cochet; Sylvain Nor 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB

## Abstract ## Objective To gain insight into the pathophysiology of an atypical familial form of an autoinflammatory disorder, characterized by autosomal‐dominant sensorineural hearing loss, systemic inflammation, increased secretion of interleukin‐1β (IL‐1β), and the absence of any cutaneous man

Leucine-rich repeat kinase 2 (LRRK2): A
Leucine-rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease
✍ Payal N. Gandhi; Shu G. Chen; Amy L. Wilson-Delfosse 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Abstract Parkinson's disease (PD) is the most common neurodegenerative movement disorder, with a prevalence of more than 1% after the age of 65 years. Mutations in the gene encoding leucine‐rich repeat kinase‐2 (__LRRK2__) have recently been linked to autosomal dominant, late‐onset PD that is cl

Night blindness–associated mutations in
Night blindness–associated mutations in the ligand-binding, cysteine-rich, and intracellular domains of the metabotropic glutamate receptor 6 abolish protein trafficking
✍ Christina Zeitz; Ursula Forster; John Neidhardt; Silke Feil; Stefan Kälin; Dorot 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB

Mutations in the GRM6 gene, which encodes the metabotropic glutamate receptor 6 (mGluR6), lead to autosomal recessive congenital stationary night blindness (CSNB), which is characterized by loss of night vision due to a defect in signal transmission from photoreceptor to the adjacent ON-bipolar cell

Genetic analysis of “leucine-rich repeat
Genetic analysis of “leucine-rich repeat (LRR) and immunoglobulin (Ig) domain-containing, Nogo receptor-interacting protein-1 (LINGO1)” in two independent Chinese parkinson's disease populations
✍ Yih-Ru Wu; Eng-King Tan; Chiung-Mei Chen; Prakash M. Kumar; Guey-Jen Lee-Chen; S 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 3 views

## Abstract A large genome‐wide association study has shown that the “leucine‐rich repeat (LRR) and immunoglobulin (Ig) domain‐containing, Nogo receptor‐interacting protein‐1 (__LINGO1__) gene” is associated with an increased risk for essential tremor (ET) recently. Given the clinical phenotype ove

Duplication of 9 base pairs in the criti
Duplication of 9 base pairs in the critical cysteine-rich domain of the RET proto-oncogene causes multiple endocrine neoplasia type 2A
✍ Dr. Wolfgang Höppner; Henning Dralle; Georg Brabant 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB

## Communicated b~ R.G.H. Cotton Activating germline mutations in the cysteine-rich domain of the RET proto-oncogene cause endocrine neoplasia type 2A, an autosomal dominant inherited cancer syndrome affecting cells derived from the neural crest, including medullary thyraid carcinoma